Altered high-energy phosphate metabolism predicts contractile dysfunction and subsequent ventricular remodeling in pressure-overload hypertrophy mice.

To study the role of early energetic abnormalities in the subsequent development of heart failure, we performed serial in vivo combined magnetic resonance imaging (MRI) and (31)P magnetic resonance spectroscopy (MRS) studies in mice that underwent pressure-overload following transverse aorta constriction (TAC). After 3 wk of TAC, a significant increase in left ventricular (LV) mass (74 +/- 4 vs. 140 +/- 26 mg, control vs. TAC, respectively; P < 0.000005), size [end-diastolic volume (EDV): 48 +/- 3 vs. 61 +/- 8 microl; P < 0.005], and contractile dysfunction [ejection fraction (EF): 62 +/- 4 vs. 38 +/- 10%; P < 0.000005] was observed, as well as depressed cardiac energetics (PCr/ATP: 2.0 +/- 0.1 vs. 1.3 +/- 0.4, P < 0.0005) measured by combined MRI/MRS. After an additional 3 wk, LV mass (140 +/- 26 vs. 167 +/- 36 mg; P < 0.01) and cavity size (EDV: 61 +/- 8 vs. 76 +/- 8 microl; P < 0.001) increased further, but there was no additional decline in PCr/ATP or EF. Cardiac PCr/ATP correlated inversely with end-systolic volume and directly with EF at 6 wk but not at 3 wk, suggesting a role of sustained energetic abnormalities in evolving chamber dysfunction and remodeling. Indeed, reduced cardiac PCr/ATP observed at 3 wk strongly correlated with changes in EDV that developed over the ensuing 3 wk. These data suggest that abnormal energetics due to pressure overload predict subsequent LV remodeling and dysfunction.

[1]  Robert G. Weiss,et al.  Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium , 2006, Circulation.

[2]  Douglas L Mann,et al.  Mechanisms and models in heart failure: the biomechanical model and beyond. , 2005, Circulation.

[3]  D. Kass,et al.  Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy , 2005, Nature Medicine.

[4]  Paul A Bottomley,et al.  ATP flux through creatine kinase in the normal, stressed, and failing human heart. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Zaccolo,et al.  cGMP Catabolism by Phosphodiesterase 5A Regulates Cardiac Adrenergic Stimulation by NOS3-Dependent Mechanism , 2004, Circulation research.

[6]  W. Kaiser,et al.  Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging , 2005, European Radiology.

[7]  E. Olson,et al.  Cardiac hypertrophy: the good, the bad, and the ugly. , 2003, Annual review of physiology.

[8]  V. P. Chacko,et al.  Regulation of murine myocardial energy metabolism during adrenergic stress studied by in vivo 31P NMR spectroscopy. , 2003, American journal of physiology. Heart and circulatory physiology.

[9]  Stefan Neubauer,et al.  Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. , 2002, Journal of the American College of Cardiology.

[10]  G. Gong,et al.  High-Energy Phosphate Metabolism and Creatine Kinase in Failing Hearts: A New Porcine Model , 2001, Circulation.

[11]  V. P. Chacko,et al.  MRI/MRS assessment of in vivo murine cardiac metabolism, morphology, and function at physiological heart rates. , 2000, American journal of physiology. Heart and circulatory physiology.

[12]  K Ugurbil,et al.  Myocardial oxygenation at high workstates in hearts with left ventricular hypertrophy. , 1999, Cardiovascular research.

[13]  B. Stoel,et al.  Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. , 1999, Circulation.

[14]  B. Lorell,et al.  Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts. , 1997, Circulation.

[15]  M. Weiner,et al.  Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. , 1995, Circulation.

[16]  T. Wallimann.  Bioenergetics: Dissecting the role of creatine kinase , 1994, Current Biology.

[17]  K. Swedberg,et al.  Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy , 1993, The Lancet.

[18]  K Ugurbil,et al.  Bioenergetic abnormalities associated with severe left ventricular hypertrophy. , 1993, The Journal of clinical investigation.

[19]  J. Ingwall.  Is cardiac failure a consequence of decreased energy reserve , 1993 .

[20]  S. Neubauer,et al.  31P Magnetic Resonance Spectroscopy in Dilated Cardiomyopathy and Coronary Artery Disease: Altered Cardiac High‐Energy Phosphate Metabolism in Heart Failure , 1992, Circulation.

[21]  K Uğurbil,et al.  31P NMR spectroscopy of the human heart at 4 T: Detection of substantially uncontaminated cardiac spectra and differentiation of subepicardium and subendocardium , 1992, Magnetic resonance in medicine.

[22]  M W Weiner,et al.  Metabolic response of the human heart to inotropic stimulation: In vivo phosphorus‐31 studies of normal and cardiomyopathic myocardium , 1992, Magnetic resonance in medicine.

[23]  G. Radda,et al.  Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy , 1991, The Lancet.

[24]  C. Hardy,et al.  Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. , 1991, American heart journal.

[25]  C. Hardy,et al.  Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. , 1990, The New England journal of medicine.

[26]  R S Balaban,et al.  Phosphorus-31 nuclear magnetic resonance analysis of transient changes of canine myocardial metabolism in vivo. , 1990, The Journal of clinical investigation.

[27]  D E Manyari,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[28]  C J Hardy,et al.  Problems and expediencies in human 31P spectroscopy. The definition of localized volumes, dealing with saturation and the technique‐dependence of quantification , 1989, NMR in biomedicine.

[29]  J. Balschi,et al.  Contractile failure and high-energy phosphate turnover during hypoxia: 31P-NMR surface coil studies in living rat. , 1987, Circulation research.

[30]  J. Ingwall,et al.  Intracellular high-energy phosphate transfer in normal and hypertrophied myocardium. , 1987, Circulation.

[31]  R S Balaban,et al.  Relation between work and phosphate metabolite in the in vivo paced mammalian heart. , 1986, Science.

[32]  R. Shemin,et al.  The creatine kinase system in normal and diseased human myocardium. , 1985, The New England journal of medicine.

[33]  W Grossman,et al.  Cardiac hypertrophy: useful adaptation or pathologic process? , 1980, The American journal of medicine.

[34]  C. Gibbs,et al.  Species differences in cardiac energetics. , 1979, The American journal of physiology.

[35]  J R Neely,et al.  Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. , 1974, Annual review of physiology.